MAPK3 and hepatocellular carcinoma: In hepatoma cells, EGCG inhibits hypoxia-induced HIF-1α accumulation through PI3K/Akt and ERK1/2 pathways, and subsequently causes a strong decrease in VEGF expression (Zhang et al., 2006).